Artera Launches with $90M for Multimodal AI, Predictive Cancer Tests
HIT Consultant
MARCH 21, 2023
What You Should Know: – Artera , the developer of multimodal artificial intelligence -based predictive and prognostic cancer tests, launches publicly today with $90M in funding. – The investment comes from a syndicate of prominent tech and healthcare investors, comprised of seven institutions (Coatue, Johnson & Johnson, Koch Disruptive Technologies, Walden Catalyst Ventures, TIME Ventures, Breyer Capital, The Factory) and 11 angel investors (Marc Benioff, Jim Breyer, Lip-Bu Tan,
Let's personalize your content